Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CTEV

Claritev (CTEV) stock: insider trades, news & valuation

Health Care · Strong buying
Close · Oct 9, 2026 $24.66 +1.4% on the day -57.7% over 12 months 52-week range $13.47 – $71.36

Share price and insider trades

CTEV closeInsider buyInsider sale
020406080NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $9,742 on 2026-03-02 · Tara O'neilBought $22,997 on 2026-03-16 · Douglas Michael GarisBought $24,859 on 2026-06-09 · Nutter CarolBought $75,036 on 2026-08-28 · Travis DaltonBought $160,000 on 2026-05-19 · John Michael PrinceBought $174,645 on 2026-08-27 · Travis DaltonBought $247,500 on 2026-03-12 · Michael KimBought $249,847 on 2025-11-20 · Travis DaltonSold $276,055 on 2026-09-21 · Douglas Michael GarisSold $288,677 on 2026-08-10 · William B. MintzBought $308,588 on 2026-05-18 · Michael Kim, Travis DaltonSold $354,620 on 2026-08-14 · Tiffani MisencikBought $426,283 on 2025-11-17 · Michael Kim, Tara O'neil, William B. MintzBought $628,940 on 2026-02-27 · Michael Kim, Travis DaltonSold $73,005,000 on 2025-11-12 · Associates Viii, L.p. H&f
Bought, 12 months$2.3M
Sold, 12 months$73.9M
Insiders buying7
Insiders selling4

Claritev insider trading at a glance (Oct 9, 2026): in the past 12 months, 7 insiders bought $2.3M and 4 sold $73.9M of CTEV stock on the open market, including a cluster buy that began May 18, 2026.

CTEV insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $676K bought (4 trades)$676KQ4 2025: $73.0M sold (6 trades)Q4 2025Q1 2026: $909K bought (5 trades)$909KQ1 2026Q2 2026: $493K bought (5 trades)$493KQ2 2026Q3 2026: $250K bought (2 trades)$250KQ3 2026: $919K sold (4 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$250K2$919K4
Q2 2026$493K5—0
Q1 2026$909K5—0
Q4 2025$676K4$73.0M6

Valuation, profit and volume

Pick score 54/100
P/E (trailing)n/aSector median 24.7
Market value$418MHealth Information Services
Profit margin-28.5%Revenue growth +6.6%
Volume vs. 50-day1.5×Last 5 sessions
Insiders' paper profit+$633KOn all tracked purchases +27.2%

Summary

Over the past 12 months, 7 Claritev Corp insiders reported open-market purchases totaling $2.3M, while 4 insiders reported sales totaling $73.9M. The most recent cluster buy began on May 18, 2026, when 3 insiders bought a combined $469K. Among insiders with enough purchase history to measure, Michael Kim (Evp, Chief Digital Officer) has the highest Insider Score at 99. 2 of 10 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

CTEV stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 22SEC Douglas Michael GarisCFO Sell Plan 7,877186,564 held (−4%) $30.50 $240K -19.1% —
Sep 22SEC Douglas Michael GarisCFO Sell Plan 1,148185,416 held (−1%) $31.19 $36K -20.9% —
Aug 31SEC Travis DaltonCEO, Chair Buy 4,50050,372 held (+10%) $38.81 $175K -36.5% 98
Aug 31SEC Travis DaltonCEO, Chair Buy 1,95052,322 held (+4%) $38.48 $75K -35.9% 98
Aug 18SEC Tiffani MisencikSvp, Chief Growth Officer Sell 8,850123,723 held (−7%) $40.07 $355K -38.5% —
Aug 12SEC William B. MintzSvp, Chief Strategy Officer Sell 8,43171,195 held (−11%) $34.24 $289K -28.0% —
Jun 10SEC Nutter CarolSvp, Chief People Officer Buy 87546,941 held (+2%) $28.41 $25K -13.2% —
May 19SEC John Michael PrinceDirector Buy 10,00031,662 held (+46%) $16.00 $160K +54.1% —
May 19SEC Travis DaltonCEO, Chair Buy 11,20045,872 held (+32%) $11.88 $133K +107.6% 98
May 19SEC Travis DaltonCEO, Chair Buy 9,72034,672 held (+39%) $12.92 $126K +90.9% 98
May 19SEC Michael KimEvp, Chief Digital Officer Buy 3,000185,878 held (+2%) $16.65 $50K +48.1% 99
Mar 16SEC Michael KimEvp, Chief Digital Officer Buy 15,000182,878 held (+9%) $16.50 $248K +49.5% 99
Mar 16SEC Douglas Michael GarisCFO Buy 1,300206,152 held (+1%) $17.69 $23K +39.4% —
Mar 2SEC Michael KimEvp, Chief Digital Officer Buy 30,000137,973 held (+28%) $14.30 $429K +72.4% 99
Mar 2SEC Travis DaltonCEO, Chair Buy 15,38024,952 held (+161%) $13.00 $200K +89.7% 98
Mar 2SEC Tara O'neilGeneral Counsel Buy 75027,199 held (+3%) $12.99 $10K +89.8% —
Nov 20SEC Travis DaltonCEO, Chair Buy 5,2909,572 held (+124%) $47.23 $250K -47.8% 98
Nov 19SEC William B. MintzSvp, Chief Strategy Officer Buy 91665,325 held (+1%) $38.00 $35K -35.1% —
Nov 18SEC Michael KimEvp, Chief Digital Officer Buy 9,600105,529 held (+10%) $38.25 $367K -35.5% 99
Nov 18SEC Tara O'neilGeneral Counsel Buy 62525,028 held (+3%) $38.84 $24K -36.5% —
Nov 14SEC Associates Viii, L.p. H&f10% Owner Sell 789,9362,024,899 held (−28%) $48.67 $38.4M -49.3% —
Nov 14SEC Associates Viii, L.p. H&f10% Owner Sell 354,524908,778 held (−28%) $48.67 $17.3M -49.3% —
Nov 14SEC Associates Viii, L.p. H&f10% Owner Sell 264,336677,590 held (−28%) $48.67 $12.9M -49.3% —
Nov 14SEC Associates Viii, L.p. H&f10% Owner Sell 66,997171,740 held (−28%) $48.67 $3.3M -49.3% —
Nov 14SEC Associates Viii, L.p. H&f10% Owner Sell 20,72253,118 held (−28%) $48.67 $1.0M -49.3% —
Nov 14SEC Associates Viii, L.p. H&f10% Owner Sell 3,4858,932 held (−28%) $48.67 $170K -49.3% —

Insiders at Claritev Corp

InsiderBoughtSoldLast filingScore
Associates Viii, L.p. H&f10% Owner — $73.0M Nov 14, 2025 —
Michael KimEvp, Chief Digital Officer $1.1M — May 19, 2026 99
Travis DaltonCEO, Chair $958K — Aug 31, 2026 98
John Michael PrinceDirector $160K — May 19, 2026 —
William B. MintzSvp, Chief Strategy Officer $35K $289K Aug 12, 2026 —
Tiffani MisencikSvp, Chief Growth Officer — $355K Aug 18, 2026 —
Douglas Michael GarisCFO $23K $276K Sep 22, 2026 —
Tara O'neilGeneral Counsel $34K — Mar 2, 2026 —
Nutter CarolSvp, Chief People Officer $25K — Jun 10, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

CTEV stock: common questions

Are Claritev Corp insiders buying CTEV stock?

In the past 12 months, 7 insiders reported open-market purchases of CTEV worth $2.3M. The latest was CEO, Chair Travis Dalton bought $175K of CTEV at $38.81.

Are Claritev Corp insiders selling CTEV stock?

4 insiders reported sales worth $73.9M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CTEV's 52-week range?

Over the past year CTEV has traded between $13.47 and $71.36. It last closed at $24.66 on Oct 9, 2026.